Product Information
FALMINA-28 TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.1535 per EA under NDC 16714035903. Its NADAC has been published 633 times since Aug 20, 2014.
FDA first approved this application on Mar 28, 2012. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
NorthStar Rx LLCNDC
16714035903
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA090721FDA Approved
3/28/2012
TE Code
AB1
On Market Since
9/13/2013
Price Statistics
The NADAC for FALMINA-28 TABLET has been published 633 times since Aug 20, 2014, and over the history we have for it it has declined 67.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1535 per EA |
|---|---|
| All-time high | $0.5937 (Apr 13, 2016) |
| All-time low | $0.1212 (Jul 17, 2024) |
| 52-week high | $0.1741 |
| 52-week low | $0.1509 |
| Median price | $0.2446 |
| Average price | $0.2919 |
| Largest weekly change | +35.3% (Jun 19, 2024) |
| Weeks tracked | 633 |
| Tracking since | Aug 20, 2014 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 27% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
levonorgestrel and ethinyl estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FALMINA-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FALMINA-28 TABLET, manufactured by NorthStar Rx LLC, is $0.1535 per EA (NDC 16714035903), effective Sep 30, 2026.
How has the price of FALMINA-28 TABLET changed over time?
Over the history we have for it, the NADAC for FALMINA-28 TABLET has declined 67.6%. It has been tracked across 633 weekly CMS publications since Aug 20, 2014.
What are the highest and lowest recorded NADAC prices for FALMINA-28 TABLET?
Since Aug 20, 2014, the NADAC for FALMINA-28 TABLET has ranged from a low of $0.1212 (Jul 17, 2024) to a high of $0.5937 (Apr 13, 2016), with a median of $0.2446 per EA.
Are there cheaper alternatives to FALMINA-28 TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVONOR-ETH ESTRAD 0.15-0.03, is $0.1128 per EA — about 27% below FALMINA-28 TABLET.
Who manufactures FALMINA-28 TABLET?
FALMINA-28 TABLET (NDC 16714035903) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.